Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00581295 · ClinicalTrials.gov registry record

Use of Diffuse Optical Spectroscopy for Evaluation of the Trauma/Critically Care Patients

A clinical trial, sponsored by University of California, Irvine.

Completed
Registry status
93
Enrollment target

NCT00581295: Completed study, sponsored by University of California, Irvine.

NCT00581295 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 93 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00581295 has completed, sponsored by University of California, Irvine.

COMPLETED
Registry status
93 participants
Enrollment target

Study Summary

Trauma remains the leading cause of death and disability for Americans age 1-44. Trauma can cause internal bleeding, and this bleeding is often hard to detect without sophisticate tests that take time to complete and analyze. In addition, internal bleeding, including bleeding into the lung and chest cavity, as well as other blood loss, happens in many critically ill patients. For example, for hemorrhage, it is very difficult to detect active hemorrhage and to determine optimal rates of fluid and blood resuscitation. Diffuse optical spectroscopy has the potential to accurately assess adequacy of tissue perfusion, oxygenation, tissue oxygen extraction, and cytochrome oxidation states that may be critical to optimal treatment, end- organ preservation, and survival.

Interventions

  • DEVICE Diffuse optical spectroscopy

Trial Details

FieldValue
Enrollment Target 93 participants
Start Date 2007-03
Est. Completion 2011-04
University of California, Irvine

368 total trials

What the finished NCT00581295 record still lists

NCT00581295 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 93 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Diffuse optical spectroscopy is the first listed.

NCT00581295 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00581295 about?

NCT00581295 is a clinical study titled "Use of Diffuse Optical Spectroscopy for Evaluation of the Trauma/Critically Care Patients". Trauma remains the leading cause of death and disability for Americans age 1-44. Trauma can cause internal bleeding, and this bleeding is often hard to detect without sophisticate tests that take time to complete and analyze. In addition, internal bleeding, including bleeding into the lung and ches...

What is the current status of trial NCT00581295?

This trial is currently completed. The enrollment target is 93 participants. The study started on 2007-03. Estimated completion is 2011-04.

What interventions are being tested in trial NCT00581295?

The interventions under investigation include: Diffuse optical spectroscopy (DEVICE).

Who is sponsoring clinical trial NCT00581295?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02203526 · 93 participants · Phase 1

    Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma

  • NCT03089554 · 93 participants · Phase 2

    Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies

  • NCT05000021 · 93 participants · NA

    Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes

  • NCT05489887 · 93 participants · Phase 2

    Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00581295, the US trial registry maintained by the National Library of Medicine. NCT00581295 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.